News

31 October 2017

Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

4 October 2017

Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer

18 September 2017

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

7 July 2017

Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK

3 July 2017

Immunocore Announces Third Oncology Target Selected in Discovery Collaboration with GlaxoSmithKline

5 June 2017

Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting

1 June 2017

Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting

12 May 2017

Abbas Hussain Joins the Board of Immunocore as Non-Executive Director

8 May 2017

Immunocore identifies second novel ImmTAC® in the GSK collaboration

5 April 2017

Immunocore Publishes Gender Pay Report

News archive